CN1211321A - 基于烟草及其燃烧副产物中存在的高级糖基化终产物的测定和处理方法 - Google Patents

基于烟草及其燃烧副产物中存在的高级糖基化终产物的测定和处理方法 Download PDF

Info

Publication number
CN1211321A
CN1211321A CN96180126A CN96180126A CN1211321A CN 1211321 A CN1211321 A CN 1211321A CN 96180126 A CN96180126 A CN 96180126A CN 96180126 A CN96180126 A CN 96180126A CN 1211321 A CN1211321 A CN 1211321A
Authority
CN
China
Prior art keywords
tobacco
ages
age
smoke
glycotoxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN96180126A
Other languages
English (en)
Chinese (zh)
Inventor
A·瑟拉米
R·J·布卡拉
H·维拉萨拉
H·W·富恩德斯
C·J·瑟拉米
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Picower Institute for Medical Research
Synvista Therapeutics Inc
Original Assignee
Alteon Inc
Picower Institute for Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alteon Inc, Picower Institute for Medical Research filed Critical Alteon Inc
Publication of CN1211321A publication Critical patent/CN1211321A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/365—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having nitrogen and sulfur as hetero atoms in the same ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES OF CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00—Tobacco smoke filters, e.g. filter tips or filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces of cigars or cigarettes
    • A24D3/06—Use of materials for tobacco smoke filters
    • A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Botany (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
CN96180126A 1995-12-26 1996-12-23 基于烟草及其燃烧副产物中存在的高级糖基化终产物的测定和处理方法 Pending CN1211321A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US921995P 1995-12-26 1995-12-26
US921895P 1995-12-26 1995-12-26
US60/009,218 1995-12-26
US60/009,219 1995-12-26

Publications (1)

Publication Number Publication Date
CN1211321A true CN1211321A (zh) 1999-03-17

Family

ID=26679210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN96180126A Pending CN1211321A (zh) 1995-12-26 1996-12-23 基于烟草及其燃烧副产物中存在的高级糖基化终产物的测定和处理方法

Country Status (7)

Country Link
EP (1) EP0877943A1 (da)
JP (1) JP2000507346A (da)
CN (1) CN1211321A (da)
AU (1) AU723649B2 (da)
CA (1) CA2241924A1 (da)
IN (1) IN191280B (da)
WO (1) WO1997023783A1 (da)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106769349A (zh) * 2017-01-06 2017-05-31 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN107202843A (zh) * 2017-06-07 2017-09-26 贵州省烟草科学研究院 LC‑MS/MS法同时测定烟草中游离氨基酸和Amadori化合物的方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5921248A (en) * 1997-03-28 1999-07-13 The Picower Institute For Medical Research Tobacco combination product filter
WO2000062626A1 (en) * 1999-04-15 2000-10-26 Fox Chase Cancer Center Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
TWI262914B (en) 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
SE0400683D0 (sv) * 2004-03-19 2004-03-19 Forskarpatent I Syd Ab Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
CN106353434B (zh) * 2016-10-21 2018-10-09 中国烟草总公司郑州烟草研究院 一种定量测定烟草中Amadori化合物的分析方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US4827949A (en) * 1987-09-16 1989-05-09 Sunas Ernest C Method of treating tobacco and tobacco produced thereby
CA1332572C (en) * 1988-01-29 1994-10-18 Anthony Cerami Method and agents for preventing staining of teeth
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
PT808163E (pt) * 1995-01-18 2003-12-31 Alteon Inc Uso de compostos de tiazolio para prevencao e inversao da formacao de produtos finais com glicosilacao avancada

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106769349A (zh) * 2017-01-06 2017-05-31 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN106769349B (zh) * 2017-01-06 2020-01-21 上海君联医疗设备有限公司 血液中异常糖基化蛋白细胞的检测方法
CN107202843A (zh) * 2017-06-07 2017-09-26 贵州省烟草科学研究院 LC‑MS/MS法同时测定烟草中游离氨基酸和Amadori化合物的方法

Also Published As

Publication number Publication date
AU1345997A (en) 1997-07-17
JP2000507346A (ja) 2000-06-13
AU723649B2 (en) 2000-08-31
EP0877943A1 (en) 1998-11-18
CA2241924A1 (en) 1997-07-03
WO1997023783A1 (en) 1997-07-03
IN191280B (da) 2003-10-25

Similar Documents

Publication Publication Date Title
JP4067562B2 (ja) 進行性グリコシル化最終生成物の生成を阻止し、反転するためのチアゾリウム化合物の使用
Mannan et al. Increased waist size and weight in relation to consumption of Areca catechu (betel-nut); a risk factor for increased glycaemia in Asians in east London
Pilny et al. Evaluation of Chlamydophila psittaci infection and other risk factors for atherosclerosis in pet psittacine birds
Nonaka et al. Time course of coproantigen excretion in Echinococcus multilocularis infections in foxes and an alternative definitive host, golden hamsters
Coop Immunotherapy for mold allergy
Larsen et al. Standardization of allergen extracts
Mcsharry et al. A review of antigen diversity causing lung disease among pigeon breeders
Huntley et al. Mapping of the rat mast cell granule proteinases RMCPI and II by enzyme‐linked immunosorbent assay and paired immunofluorescence
CN1211321A (zh) 基于烟草及其燃烧副产物中存在的高级糖基化终产物的测定和处理方法
Satarug et al. Thiocyanate-independent nitrosation in humans with carcinogenic parasite infection
Sapsutthipas et al. Effective equine immunization protocol for production of potent poly-specific antisera against Calloselasma rhodostoma, Cryptelytrops albolabris and Daboia siamensis
Zuskin et al. Immunological and respiratory findings in swine farmers
US6110968A (en) Methods for treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
US5850840A (en) Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
Magnaval et al. Eosinophil cationic protein, specific IgE and IgG4 in human toxocariasis
Enriquez Diaz Variabilité et bioénergétique de la reproduction chez l'huître creuse Crassostrea gigas
Klassen et al. Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody
Breijo et al. Echinococcus granulosus: an intraperitoneal diffusion chamber model of secondary infection in mice
WO1997023783A9 (en) Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
JP2009073783A (ja) 魚類由来抗体の製造方法
US5854000A (en) Methods for measurement predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
CN103792350A (zh) 一种检测呋喃丹的快速检测试剂板的制备方法
WO2012173244A1 (ja) 人獣共通感染性歯周病菌検出用マーカー
MXPA98005261A (en) Methods to measure and treat the pre-calculated calculation on the presence of final products of advanced glicosilation in tobacco and in its combust subproducts
Seleim et al. ELISA and other tests in the diagnosis of Pasteurella multocida infection in camels

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication